FDA has announced it has approved Linzess (linaclotide) to treat chronic idiopathic constipation and to treat irritable bowel syndrome with constipation in adults, according to a news release. Linzess ...
Hosted on MSN
Ibsrela vs. Linzess: How Do They Compare for IBS-C?
Irritable bowel syndrome with constipation (IBS-C) is characterized by symptoms such as irregular bowel movements, abdominal pain, and bloating. The U.S. Food and Drug Administration (FDA) has ...
Many Medicare Part D plans cover Linzess, but out-of-pocket costs can vary because private insurance companies manage these plans. Linzess is an expensive medication with no generic alternatives ...
Linzess is a brand-name oral capsule prescribed for certain types of constipation in adults and some children. It contains the active ingredient linaclotide. It’s not known whether Linzess is safe to ...
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused healthcare company, today announced that the U.S. Food and Drug Administration (FDA) approved a revised label for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback